Activation of immuno-responsive cells via a variety of membrane receptors are frequently coupled to the activation of various sequential kinase cascades. 1, 2) In general, receptor activations often lead to the stimulation of mitogen-activated protein kinases (MAPKs), IkB kinases (IKKs) and Janus kinases (JAKs). Different subtypes of MAPKs including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 MAPK regulate the stimulatory phosphorylation of transcription factors, such as Elk, c-Jun and ATF-2.
3) The IKKs mediate the activation of nuclear factor kB (NFkB) via a series of phosphorylation and proteosomemediated events, 4) and the JAKs phosphorylate and stimulate the activities of various isoforms of signal transducer and activator of transcription (STAT). 5) Increased activities of these intracellular signaling events often result in the activation of immuno-responsive cells, and the subsequent enhanced production of cytokines which serve as modulators for different phases of the immune response. 6) Hence, detection of the signaling intermediates in their stimulatory phosphorylated forms and the production of cytokines can serve as useful indicators of whether the administration of a pharmacological agent is linked to immuno-modulatory effects.
CKBM is an herbal formula composed of Ginseng (Panax ginseng), Wu Wei Zi (Schisandra chinensis), Hawthorn (Fructus crataegi), Jujube (Ziziphus jujube) and Soybean (Glycine Max), supplemented with baker's yeast (Saccharomyces cerevisiae). All of the herbal components in CKBM are defined as therapeutic agents in terms of Chinese medicine, and consumed by millions of people for many centuries. The water extract of Panax ginseng stimulates the immune responses in both helper and cytotoxic T lymphocytes, 7) and some of its chemical constituents (e.g. ginsenoside Rg1) have a protective effect against neurodegenerative diseases.
8) Schisandra chinensis contains lignans which are effective apoptotic agents against lung carcinoma cells 7) and may act as an enhancing agent in the treatment for acute promyelocytic leukemia.
9) The quercetin in Fructus crataegi is anti-inflammatory as demonstrated by its inhibitory effect on TNFa release from macrophages. 10) Betulinic acid, a potential anti-viral agent for HIV, 11) is a chemical constituent in Ziziphus jujube. Glycine Max contains isoflavones, which help to reduce the risk of breast cancer, 12) while soluble bglucan obtained from processed Saccharomyces cerevisiae binds to the complement receptors in natural killer cells for the priming of tumoricidal functions. 13) All the above findings suggest that CKBM is an herbal formula with multiple components of different functions, ranging from immuno-modulation, anti-viral, to anti-cancer activities. Hence, CKBM may serve as a potential therapeutic agent which provides both physiological and mental relief. In fact, CKBM is capable of stimulating immuno-activities by triggering the release of IL-6 and TNFa from human peripheral blood mononuclear cells, 14) induce phagocytic activities in macrophage 15) and its anti-tumorigenic activity against gastric cancer 16) and liver cancer 17) has been demonstrated in nude mice. In this report, we will focus on the immuno-modulatory function of CKBM, by further exploring how this herbal formula regulates the intracellular signaling of monocytic cells and the subsequent cytokine production. ); and those for anti-ERK, anti-JNK, anti-p38, anti-NFkB, anti-STAT1, anti-STAT3 and anti-STAT5 were from Cell Signaling Technology (Beverly, MA, U.S.A.). The multiplex fluorescent bead immunoassay for human cytokine production was from Bender MedSystems (Vienna, Austria). CKBM was provided by CK Life Sciences Int'l., Inc. (Hong Kong). It was centrifuged (4000 rpm, 30 min) at 4°C, and the supernatant was then sterilized by 0.22 mM syringe filters. The filtrates were gently mixed well and stored at 4°C in dark.
Immuno-regulatory Effects of CKBM on the
Cell Culture THP-1 cells were cultured in RPMI 1640 medium containing 10% (v/v) fetal bovine serum (FBS), 4.5 g/l glucose, 1 mM sodium pyruvate and 0.05 mM 2-mercaptoethanol. 50 units/ml penicillin and 50 mg/ml streptomycin were incorporated in the growth medium, and the cells were grown at 37°C in an environment of 5% CO 2 .
Detection of Stimulatory Phosphorylated MAPKs, NFk kB and STATs The detection of stimulatory phosphorylated MAPKs was performed as described previously. 18) Briefly, serum-starved THP-1 cells were maintained at a density of 10 6 cells/ml in the absence or presence of CKBM for various time intervals. The drug treatment was terminated by centrifugation (1000 rpm, 2 min) at 4°C, followed by aspiration of drug-containing medium and addition of 250 ml icecold lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM EDTA, 40 mM NaP 2 O 7 , 1% Triton X-100, 1 mM DTT, 200 mM Na 3 VO 4 , 100 mM PMSF, 2 mg/ml leupeptin, 4 mg/ml aprotinin and 0.7 mg/ml pepstatin). Fifty micrograms of protein (for each sample) were resolved in 12% SDS-PAGE and followed by Western blotting. The presence of stimulatory phosphorylated MAPKs (i.e. ERK, JNK and p38), NFkB, STATs, and their endogenous expression level in THP-1 cells were detected by specific antibodies as described in Materials. Finally, the membranes were developed in the presence of ECL TM reagents, and the images detected in X-ray films were quantified by densitometric scanning using the Eagle Eye TM II still video system (Stratagene). Detection of Cytokine Production Serum-starved THP-1 monocytic cells (1ϫ10 6 cells in 500 ml of RPMI) were treated with increasing concentrations of CKBM (0-20%) in the absence or presence of A23187 (5 mM) for 18 h. The cytokine-containing supernatants were collected by spinning at 1000 rpm for 2 min in a bench centrifuge. Detection of various cytokines (i.e. IL-1b, IL-4, IL-6, IL-10, IFNg, TNFb) was performed as described by the supplier (Bender MedSystems). Briefly, 25 ml of supernatant from each sample was transferred to designated sample tubes, followed by addition of bead mixture and diluted biotin-conjugate for specific cytokine binding. The contents of each tube were wellmixed and incubated at room temperature for 2 h. The resulting immuno-complexes were washed twice, followed by addition of diluted buffer of streptavidin-PE which binds the biotin-conjugate and emit fluorescent signals. After 1 h incubation at room temperature the immuno-complexes were washed twice again, and then suspended in 500 ml of the provided assay buffer. The bead suspensions were analyzed by a flow cytometer in accordance to the supplier's instruction. Cytokine standards for quantification as well as the blanks were handled in the same manner as the samples. 14) has demonstrated that CKBM is capable of inducing the production of cytokines in human peripheral blood mononuclear cells including lymphocytes and monocytes. In order to better define the possible CKBM-induced effects on distinct immuno-responsive cell types, monocytic THP-1 cells were chosen as a cellular model in this report. We began with 20% of CKBM at which no significant cell death of THP-1 cells were observed for overnight treatment (data not shown), and then studied the intracellular signaling of the cells upon different treatment periods (0-60 min) as well as concentrations (0-20%). Figure 1 showed that treatment of THP-1 cells with CKBM (20%) had no significant effects on the ERK subgroup of MAPK for up to 60 min (Fig. 1A) . However, the same concentration of CKBM elicited differential effects on the JNK and p38 subgroups of MAPK. The basal stimulatory JNK phosphorylation decreased rapidly within the first 10 min of CKBM treatment, and maximal inhibition (ca. 80%) was observed around 15 min of treatment (Fig.  1B) . In contrast, the stimulatory phosphorylation of p38 increased very rapidly upon CKBM treatment, reaching the maximal (ca. 6 to 7 folds as compared with the basal which was defined as 1.0 fold) at 15 min of treatment (Fig. 1C) .
RESULTS

Differential Regulation of MAPK Activation in THP-1 Monocytic Cells Treated with CKBM A previous study
Dose-Dependent Regulation of MAPK in THP-1 Cells Treated with CKBM As suggested CKBM was able to regulate the three classic MAPK subgroups in a differential manner (Fig. 1) , we then further investigated the dose-dependency of this effect by treating the cells with increasing concentrations of CKBM. Throughout the range of concentration examined (0-20%), the stimulatory phosphorylation of ERK was not significantly changed as compared with the basal (Fig. 2A) . The level of JNK phosphorylation showed a gradually decrease when the applied dosage of CKBM was increased from 0 to 10%, with 15% and 20% of this agent inducing the maximal suppressive effect (Fig. 2B) . A dose-dependent activation of p38 was associated with increasing concentrations of CKBM as illustrated in Fig. 2C , while 15% of the agent was sufficient to trigger the maximal activation (Fig. 2C) .
CKBM Did Not Effectively Enhance the Stimulatory Phosphorylation Levels of Nuclear Factor-k kB (NFk kB) and Signal Transducer and Activator of Transcription (STAT) In addition to the activation of MAPK subgroups, kinases such as IKKs and JAKs also serve as critical upstream intermediates for regulating transcriptional activities of NFkB and STATs, which in turn may participate in the induction of various cytokines.
6) When THP-1 monocytic cells were stimulated individually with TNFa, IFNa and IL-6, which serve as extracellular activating signals for the stimulation of NFkB, STAT1/5 and STAT3, respectively, the stim- ulatory phosphorylation of these transcription factors could be easily detected by their corresponding antibodies (Fig. 3) . However, Administration of CKBM (20%, for 5 min or 15 min) neither effectively activated NFkB, nor triggered stimulation of STAT1, STAT3 and STAT5 (Fig. 3) . It should be noted that significant activation of the p38 MAPK can be detected upon CKBM treatment for 5 to 15 min (Figs. 1, 2) .
Treatment of CKBM Triggered the Release of Interleukin-10 (IL-10) and Interferon-g g (IFNg g) from THP-1 Monocytic Cells Activation of MAPK, particularly the stimulation of p38 subgroup has been demonstrated as one of the critical signals to trigger the cytokine production from immuno-responsive cells. The ability of CKBM to induce p38 activation in THP-1 cells implied that production of cytokines could be initiated upon treatment with CKBM. To test this hypothesis, a multiplex fluorescent bead immunoassay (Bender MedSystems, Vienna) for human cytokine production was applied. We found that CKBM at 20% stimulated THP-1 cells to release IL-10, and triggered a weak but significant production of IFNg (Table 1) . However, the production of IL-1b, a cytokine primarily released from monocytic cells, was not significantly increased by the same treatment (Table 1) . Other cytokines including IL-4, IL-6 and the T cell-specific cytokine likes TNFb (a negative control) were not effectively induced upon the same treatment (Table 1) . (Table 1) . However, IL-10 production was significantly increased to a level around 50% of the CKBMinduced response (Table 1) . When CKBM (20%) and A23187 (5 mM) were co-administrated to the same cells, dramatic changes in the cytokine production were observed. The co-operative effect of CKBM and A23187 produced a synergistic production of IL-1b, IL-6 and IFNg (Table 1 ). In contrast, A23187 neither potentiated the CKBM-induced IL-10 production, nor enabled CKBM-treated cells to effectively produce IL-4 and TNFb (Table 1) . Our control experiment showed that A23187 alone weakly activated the MAPK subtypes. However, it did not alter the CKBM-induced MAPK activity profile upon co-administration (Fig. 4) . Co-stimulation of CKBM and A23187 remained unable to activate NFkB and STATs (data not shown). It should be noted that the synergistic production of IL-6 was not comparable to those of IL-1b and IFNg (Table 1) .
The A23187-Induced Potentiation of IL-1b b and IFNg g THP-1 cells were treated with CKBM (20%) and A23187 (5 mM) individually or simultaneously for 18 h. The resulting medium were incubated with a bead mixture with diluted biotin-conjugate for specific cytokine binding, followed by addition of streptavidin-PE which binds the biotin-conjugate and emit fluorescent signals. The bead suspensions were subsequently analyzed by a flow cytometer for the detection of specific cytokines. Data shown represent the meanϮS.E. from three individual experiments, with the unit designated as pg/ml. a) Treatment of CKBM or A23187 significantly induced the production of cytokines. # Simultaneous treatment of CKBM and A23187 triggered a synergistic production of cytokines; Bonferroni's corrected t-test, two-way ANOVA, pϽ0.05.
Fig. 4. A23187 Could Not Alter the MAPK Activity Profile Mediated by CKBM
THP-1 cells were stimulated individually or simultaneously with CKBM (20%) and A23187 (5 mM) for 15 min. Lysate of each sample was resolved in 12% SDS-PAGE, followed by immunoblotting with specific antibodies to detect the stimulatory phosphorylated forms (P) of ERK, JNK and p38, as well as their total expression levels (T).
Production Was Dose-Dependent on CKBM
We have demonstrated that the most significant changes in cytokine induction upon CKBM/A23187 co-treatment was the synergistic production of IL-1b and IFNg (Table 1) . Further analysis was then performed to investigate the effect of CKBM dosage in the presence of the potentiation effect from A23187. When A23187 (5 mM) was constantly administered, the synergistic induction of IL-1b and IFNg showed a dosedependent characteristic on CKBM. The synergism of IL-1b production appeared when the CKBM concentration was increased from 10% or above (Fig. 5A) ; while the same potentiation effect on IFNg production was more sensitive towards the CKBM concentration, with maximal synergism occurring when CKBM was increased from 2.5 to 5%; further increase of CKBM dosage (10-20%) remained effective for inducing this synergistic response (Fig. 5B) .
DISCUSSION
Numerous studies have demonstrated that the therapeutic effects of Chinese medicinal herbs are due to the presence of chemical constituents with specific biological effects. 12, 19) The five medicinal herbs in CKBM contain different chemical constituents capable of modulating immunity, thus providing physiological relief against various diseases. The dose-dependent characteristics of CKBM-induced p38 responses in THP-1 cells were gradually increased at low concentration ranges, and achieved maximal activities when the dosage is further increased (Fig. 2) . This indicates that the active constituents in CKBM are likely to act on specific cellular targets which become saturated when the CKBM concentration is gradually increased. Although the direct molecular targets of these chemical constituents have not been fully defined, the immuno-modulatory effects of some CKBM herbal components have been well-established, 7, 10) and their clinical value proven through the prescription of traditional Chinese medicine.
Ginsenoside Rd and ginsenoside Rg1 are two major components in Panax ginseng; the former attenuates the LPS/TNFa-induced stimulatory phosphorylation of ERK, 20) while the latter exhibits its anti-apoptotic activity by inhibiting the JNK subgroup of MAPKs. 8) Fructus crataegi contains chlorogenic acid which is capable of triggering p38 activation in chronic myelogenous leukemia cells; 21) while betulinic acid isolated from Ziziphus jujube also shows a stimulatory effect on p38 in human melanoma cells. 22) All these findings suggest that the differential regulation of MAPK described in this report is likely to be the integrated effects of various chemical components in CKBM, resulting in a persistent activation of p38, an inhibitory effect on JNK and a lack of ERK regulation in THP-1 cells (Fig. 1) .
Administration of CKBM alone was associated with a significant production of IL-10, which could not be further potentiated by the Ca 2ϩ -elevating effect of A23187. It implied that p38 activation upon CKBM treatment was probably sufficient to fulfill the basic requirement for triggering IL-10 induction. This assumption is supported by the previous finding that IL-10 production in immuno-responsive cells shows a high dependence on the p38 signaling cascade. 23) Conversely, lipopolysaccharide (LPS) triggers activation of JNK and p38 but not ERK, 24) and the LPS-mediated p38 activation has been shown to be the most critical MAPK signaling for the production of IL-1b. 25) The biological significance of CKBM-induced JNK inhibition (Figs. 1B, 2B ) remains unclear, but it has been suggested that JNK may act as a suppressive signal for the production of certain cytokines. 24) Further investigation is thus required to determine whether JNK also possesses an inhibitory effect on the IL-1b production. In monocytic THP-1 cells, the IL-1b production in response to LPS was highly potentiated by the Ca 2ϩ ionophore A23187, while LPS itself does not elevate the intracellular Ca 2ϩ level. 26) All these findings suggested that p38 activation and Ca 2ϩ elevation are two possible signaling events involved in the multiple pathway-regulated IL-1b production. IFNg is produced by T lymphocytes in a p38-dependent manner, 27) with an enhancing effect on the phagocytosis of macrophage and immunoglobulin secretion of B lymphocytes. However, a recent report has demonstrated that IFNg can also be produced by THP-1 monocytic cells. 28) Although the signaling mechanism for inducing IFNg from monocytes remains unclear, the CKBM/A23187-induced synergistic IFN 28) production implied that it may operate in a similar manner to that of IL-1b CR3 (i.e. CD11b/CD18) is a b 2 integrin which plays a key role in antimicrobial defenses, and it is expressed in the plasma membrane of monocytes and neutrophils. 29) ICAM-1, the best-characterized cellular ligand for CD11b/CD18, is strongly induced in various tissues during viral infection and inflammation. 30) Engagement and clustering of CD11b/CD18 integrin leads to increased cytosolic Ca 2ϩ concentration in monocytes. 31) However, it has not been reported that CD11b/CD18 signaling is linked to p38 activation. This physiological phenomenon suggest that the CD11b/CD18-mediated Ca 2ϩ signal may be capable of co-operating with a p38-activating agent (e.g. CKBM), for the synergistic production of cytokines like IL-1b and IFNg. It also implies that CKBM may serve as an enhancing, or priming agent for immuno-responses, by co-operating with the classical monocyte signaling under infection and inflammatory conditions. Although the present report implicates possible roles of p38 and Ca 2ϩ for the synergism of cytokine production, it should be noted that intracellular signaling cascades other than MAPKs, NFkB 32) and STATs 33) may also be stimulated in response to CKBM and Ca 2ϩ -mediated signaling. Further investigations may help to refine the signal integration for CKBM/A23187-induced synergism.
Administration of a low concentration of CKBM (1%) is incapable of inducing the production of IL-10 and IFNg in human peripheral blood mononuclear cells such as lymphocytes and monocytes. 14) However, as demonstrated in this report, higher concentrations of CKBM were capable of triggering significant induction of IL-10, and weakly enhanced the IFNg production of THP-1 monocytic cells. Generation of an elevating Ca 2ϩ signal even synergized the production of IL-1b and IFNg when accompanied with CKBM treatment. IL-1b is a pro-inflammatory cytokine which augments T lymphocytes responses to mitogens and indirectly activates B lymphocytes. 34) IFNg also serves as a pro-inflammatory cytokine by activating macrophages as well as inducing other cytokine production. 35) IL-10, a cytokine with anti-inflammatory effects on macrophages, also possesses stimulatory effects on the proliferation and antibody production of B lymphocytes. 36) Taken together, the immuno-regulatory effects of CKBM on THP-1 cells suggest that it is an effective agent for stimulating the immuno-activities of monocytes. Further investigations should be focused on other immuno-responsive cell types to explore the overall immuno-modulatory effects of CKBM.
